Actively Recruiting

Age: 18Years - 89Years
All Genders
Healthy Volunteers
NCT07502989

Muscle Health Measurements Using Electrical Impedance Myography

Led by Beth Israel Deaconess Medical Center · Updated on 2026-04-03

150

Participants Needed

1

Research Sites

125 weeks

Total Duration

On this page

Sponsors

B

Beth Israel Deaconess Medical Center

Lead Sponsor

N

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is being done to further develop a device, the mScan, to measure muscle health as compared to measurements of muscle health using MRI (magnetic resonance imaging). This device is held against the skin and uses Electrical Impedance Myography (EIM). EIM uses a very small, noninvasive (e.g. no needles), brief (about 6 seconds), and painless electrical current to measure the muscle. The investigators will look at how the mScan predicts the muscle measurements seen on MRI in people with and without muscle disease. The investigators hope that this can be used in the future as a quick, convenient and less time-consuming way than MRI to assess muscle health. This could be used to measure how well treatments for different muscle disorders are working over a period of time.

CONDITIONS

Official Title

Muscle Health Measurements Using Electrical Impedance Myography

Who Can Participate

Age: 18Years - 89Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Ages 18 to 89 years
  • Evidence of a primary myopathic condition confirmed by chart review, genetic testing, serology, or previous muscle biopsy
Not Eligible

You will not qualify if you...

  • Unable to lie flat or history of claustrophobia
  • More than 1+ lower extremity edema
  • Multiple other muscle pathologies affecting lower extremity muscles to be studied
  • Pregnancy
  • Contraindications for MRI such as incompatible pacemaker, deep brain stimulator, or lower extremity hardware
  • Contraindications to DXA Scan including recent radioisotope studies (within 15 days), recent radiographic contrast imaging (within 7 days), weight over 450 lbs, or recent calcium supplements/antacids (within 24 hours)
  • Severe obesity with BMI over 35 kg/m2
  • Chronic skin conditions with ulcerations interfering with EIM electrode contact or causing discomfort

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here